Number of eyes | | 79 eyes | 17 eyes | 14 eyes | 10 eyes | 11 eyes | 52 eyes |
Mean follow up | | 24 months | 26 months (6–18 months) | 11 months (6–24 months) | 15.7 months (3–28 months) | 9.82 months (6–18 months) | 32 months (6–59 months) |
Mean baseline VA | | 20/125 | 20/140 | 20/250 | 20/167 | 20/133 | 20/122 |
Mean final VA | | 20/80 | 20/124 | 20/100 | 20/40 | 20/87 | 20/81 |
Change in VA | | Improved by 2.0 lines | Improved by 0.6 lines | Improved by 3.8 lines | Improved by 6.3 lines | Improved by 0.7 lines | Improved by 1.7 lines |
Improvement by 2 lines of more | | 56% | 29% | 50% | 100% | 36% | 55% |
Final VA of 20/40 or better | | 24% | – | 21% | 60% | 9% | 39% |
Mean foveal displacement | | 942 μm | 1245 μm | 695 μm | 1170 μm | 854 μm | 2100 μm |
Complications | | Retinal break (21.5%), choroidal haemorrhage (3.7%), insufficient foveal displacement (20%), retinal detachment (8.8%), subfoveal recurrence (28%), macular fold (2.8%) and macular hole (1.2%) | CNV enlargement (53%), atrophy of retina/RPE/choroid (18%) | Recurrence of CNV (14%), retinal detachment (14%), Macular hole (7%), transient diplopia (14%), transient hyphaema (7%) | Vertical and torsional diplopia (20%), 2 iatrogenic retinal breaks (20%), all with mild retinal pigment epithelial damage, recurrent subretinal haemorrhage (30%) | 2 retinal detachment (18%), 1 culture negative endophthalmitis (9%), 1 macular hole (9%) | Retinal detachment (34%), diplopia (29%), recurrence of CNV (6%) |